News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Apira Science Successfully Completes Clinical Trial For The Treatment Of Androgenetic Alopecia In Females


3/18/2014 9:49:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

IRVINE, Calif.--(BUSINESS WIRE)--Apira Science, Inc. today announced that it has successfully completed a clinical trial using its iGrow® Hair Growth System to promote hair growth in females. The study found promising results for the use of low-level laser therapy (LLLT) in increasing terminal hair counts in women. The iGrow Hair Growth System is a highly effective, in-home, hands-free LLLT hair growth device that has already been cleared by the FDA to promote hair growth in males.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES